ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy.
ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy.
复制标题
DOI：
10.1016/j.ekir.2016.07.007
复制
发表时间：
2016-09
影响因子：
6
通讯作者：
Gonzalez FJ
中科院分区：
文献类型：
--
作者：
Zheng B;Chen L;Gonzalez FJ
Diabetic nephropathy (DN) is the major reason for end-stage renal disease in the Western world. Patients with DN developed more severe cardiovascular complications with worse prognosis. In spite of tight blood pressure and glucose control through applying angiotensin Ⅱ receptor antagonism, angiotensin receptor inhibitors, and even direct renin inhibitors, the progression and development of DN has continued to accelerate. Nuclear receptors are, with few exceptions, ligand-depended transcription factors, some of which modulate genes involved in the transport and metabolism of carbohydrates or lipids, and in the modulation of inflammation. Considering the diverse biological functions of nuclear receptors, efforts have been made to explore their contributions to the pathogenesis of DN and their potential in therapeutic strategies. This review is mainly focused on the association between various nuclear receptors and the pathogenesis of DN, the potential beneficial effects of targeting these receptors for treating and preventing the progress of DN, and the important role that nuclear receptors may play in future therapeutic strategies for DN.
